Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

NorthX Biologics AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 118,101 Less Arrow 73,548 More Arrow 106,208
Financial expenses 614 Less Arrow 142 More Arrow 527
Earnings before taxes -37,317 Less Arrow -49,539 More Arrow -7,847
EBITDA -26,628 Less Arrow -42,047 More Arrow -2,897
Total assets 214,969 More Arrow 241,266 Less Arrow 184,707
Current assets 104,293 More Arrow 111,714 Less Arrow 92,240
Current liabilities 214,093 Less Arrow 210,079 Less Arrow 179,428
Equity capital 806 More Arrow 31,187 Less Arrow 5,279
- share capital 65 More Arrow 67 Equal arrow 67
Employees (average) 116 More Arrow 145 Less Arrow 129

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 0.4% More Arrow 12.9% Less Arrow 2.9%
Turnover per employee 1,018 Less Arrow 507 More Arrow 823
Profit as a percentage of turnover -31.6% Less Arrow -67.4% More Arrow -7.4%
Return on assets (ROA) -17.1% Less Arrow -20.5% More Arrow -4.0%
Current ratio 48.7% More Arrow 53.2% Less Arrow 51.4%
Return on equity (ROE) -4629.9% More Arrow -158.8% More Arrow -148.6%
Change turnover 46,986 Less Arrow -33,207 More Arrow 13,625
Change turnover % 66% Less Arrow -31% More Arrow 15%
Chg. No. of employees -29 More Arrow 16 Less Arrow 5
Chg. No. of employees % -20% More Arrow 12% Less Arrow 4%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.